IMMUNOTHERAPEUTIC TARGETS AGAINST STAPHYLOCOCCUS AUREUS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 30, 2016
app pub date -
Dec 18, 2015
filing date -
Dec 18, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The subject invention pertains to vaccine formulations and antibodies, and related methods, for the treatment and/or prevention of S. aureus infection. The present invention provides one or more S. aureus antigens for use in vaccine formulations, wherein two or more antigens act synergistically. Further, the present invention provides vaccines that can protect against hematic spread, pneumonia and skin infection.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully